Cefrik CV 200mg/125mg Tablet
By Cefrik CV
Rx
6 Tablet in a Strip

Composition
Cefixime(200mg) + Clavulanic Acid(125mg)

Manufacturer - Medcover Pharmaceuticals (OPC) Private Limited
C/O ABHISHEK, NEAR SHIV CHOWK V.P.O BILASPUR JAGADHRI YAMUNA NAGAR HR 135102 IN

Expires on or after
July, 2025

liver
When using Cefrik CV 200mg/125mg Tablet, it is important to exercise caution in individuals with liver disease. Adjustment of the dosage of Cefrik CV 200mg/125mg Tablet may be necessary for patients with liver conditions. Therefore, it is advised to seek guidance from your doctor before starting or continuing the use of this medication to ensure safe and effective treatment.

kidney
Cefrik CV 200mg/125mg Tablet requires caution in kidney disease. It may require dose adjustment. Consult your doctor.

alcohol
Caution is recommended when alcohol is consumed with Cefrik CV 200mg/125mg Tablet. It's advisable to consult your doctor.

driving
Cefrik CV 200mg/125mg Tablet can cause side effects like allergic reactions, dizziness, or fits, which may impair driving ability.It is best to consult your doctor before driving while taking this medication.

pregnancy
Cefrik CV 200mg/125mg Tablet is generally safe in pregnancy with minimal risk to the baby based on animal studies. Limited human studies are available, so consulting a doctor before use is advisable.

breastfeeding
Cefrik CV 200mg/125mg Tablet is considered safe for breastfeeding. Studies show minimal transfer of the drug into breastmilk, posing no harm to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹172
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024